期刊文献+

雷帕霉素诱导人肝癌细胞BEL-7402凋亡中Bcl-2作用研究 被引量:8

Role of Bcl-2 in apoptosis induced by Rapamycin on hepatocelluar carcinoma BEL-7402 Cells
下载PDF
导出
摘要 目的探讨雷帕霉素(rapamycin,RAPA)体外对肝癌BEL-7402细胞生长抑制及诱导细胞凋亡中的作用及Bcl-2变化在凋亡机制中的意义。方法以5、10、20、30、40和50nmol/L不同浓度的RAPA作用于体外培养的BEL-7402细胞,MTT法检测细胞生长抑制率,应用流式细胞仪检测细胞凋亡,Hoechst33258荧光染色法观察细胞凋亡时的形态学变化,Westernblot观察Bcl-2、Bcl-xl和bax等凋亡相关表达变化。结果RAPA可显著抑制BEL-7402细胞的生长,诱导细胞发生凋亡,并呈现出明显的量-效与时-效关系。RAPA作用肝癌细胞BEL-740248h后,在Hoechst33258荧光染色图片上可见核浓缩及核碎裂等典型的细胞凋亡特征,凋亡过程中伴有抗凋亡蛋白Bcl-2、Bcl-xl表达的降低和促凋亡蛋白bax上调。结论RAPA可能通过诱导抗凋亡蛋白Bcl-2、Bcl-xl表达的降低和促凋亡蛋白bax表达上调而诱导凋亡发生,抑制BEL-7402细胞的生长。 OBJECTIVE: To investigate cell growth inhibition and apoptosis induced by rapamycin on human hepatocelluar carcinoma BEL-7402 cells and the role of Bcl-2 in its action mechanism, METHODS: BEL-7402 cells were given in culture medium with rapamycin in different concentrations, 5, 10, 20, 30, 40 and 50 nmol/L. Cell viability was assessed by MTT assay. Cell apoptosis was observed by Hoechst 33258 staining and flow cytometry (FCM), The Bcl-2 apoptotic related genes were assayed by Western blotting. RESULTS.. Rapamycin inhibited the growth of EEL-7402 cells and induced apoptosis significantly in time-and dose-dependent manner. Marked morphological changes of apoptosis were observed by Hoechst 33258 staining after the cells were exposed to rapamycin for 48 h. Western blotting analysis demonstrated that anti-apoptotic protein Bcl-2 and Bcl-xl were downregulatd while pro-apoptotic protein bax was upregulated remarkably in a time dependent manner when apoptosis ocurred. CONCLUSION: Rapamycin has significant antiproliferation effect by induction of apoptosis with downregulation of anti-apoptotic protein Bel-2, Bel-xl and upregulation of pro-apoptotic protein bax.
出处 《中华肿瘤防治杂志》 CAS 2006年第19期1445-1448,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 国家973重点发展研究计划基金(2003CB515507)
关键词 肝肿瘤/药物作用 西罗莫司/药理学 基因 BCL-2 流式细胞术 细胞凋亡 liver neoplasms/drug action sirolimus/pharmacology genes, Bcl-2 flowcyctometry apoptosis
  • 相关文献

参考文献10

  • 1Niemczyk M,Nowak M,Pilecki T,et al.Economic evaluation of sirolimus-based immunosuppressive regimens in kidney graft recipients[J].Transplant Proc,2006,38 (1):74-77.
  • 2Oldakowska-jedynak U,Paczek L,Mucha K,et al.Successful reversal of acute vascular rejection and cyclosporine-associated nephrotoxicity in renal allograft with combined sirolimus and mycophenolate mofetil as immunotherapy[J].Transplant Proc,2006,38(1):66-68.
  • 3Stephan S,Datta K,Wang E,et al.Effect of Rapamycin alone and in combination with antiangiogenesis therapy in an orthotopic model of human pancreatic cancer[J].Clin Cancer Res,2004,10(20):6993-7000.
  • 4Boffa D J,Luan F,Thomas D,et al.Rapamycin inhibits the growth and metastatic progression of non-small cell lung cancer[J].Clin Cancer Res,2004,10(1 Part 1):293-300.
  • 5Wiedmann M W,Caca K.Molecularly targeted therapy for gastrointestinal cancer[J].Curr Cancer Drug Targets,2005,5(3):171-193.
  • 6Rathmell W K,Wright T M,Rini B I.Molecularly targeted therapy in renal cell carcinoma[J].Expert Rev Anticancer Ther,2005,5(6):1031-1040.
  • 7Luan F L,Ding R,Sharma V K,et al.Rapamycin is an effective inhibitor of human renal cancer metastasis[J].Kidney Int,2003,63 (3):917-926.
  • 8Yoshiji H,Kuriyama S,Yoshii J,et al.Vascular endothelial growth factor tightly regulates in vivo development of murine hepatocellular carcinoma cells[J].Hepatology,1998,28(6):1489-1496.
  • 9Farroew S N,White J H,Martinou I,et al.Cloning of a Bcl-2 homologue by interaction with adenovirus EIB19K[J].Nature,1995,374(6524):731-733.
  • 10Krajewski S,Krajewska M,Shabaik A,et al.Immunohistochemical determination of in vivo distribution of Bax,a dominant inhibitor of Bcl-2[J].Am J Pathol,1994,145(6):1323-1336.

同被引文献101

引证文献8

二级引证文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部